Sodium borohydride → HCID 11419613, compound
Reaction equation
[CH3:1][C:2]([CH3:33])([CH3:32])[C:3](=[O:31])[CH2:4][O:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]([C:17]2[CH:18]=[CH:19][C:20]3[O:24][C:23]([C:25]([OH:27])=[O:26])=[C:22]([CH3:28])[C:21]=3[CH:29]=2)([CH2:15][CH3:16])[CH2:13][CH3:14])=[CH:8][C:7]=1[CH3:30].[BH4-].[Na+]>>[CH2:13]([C:12]([C:17]1[CH:18]=[CH:19][C:20]2[O:24][C:23]([C:25]([OH:27])=[O:26])=[C:22]([CH3:28])[C:21]=2[CH:29]=1)([C:9]1[CH:10]=[CH:11][C:6]([O:5][CH2:4][CH:3]([OH:31])[C:2]([CH3:32])([CH3:33])[CH3:1])=[C:7]([CH3:30])[CH:8]=1)[CH2:15][CH3:16])[CH3:14]Participants
3
Procedure
5-{1-[4-(3,3-Dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethyl-propyl}-3-methyl-benzofuran-2-carboxylic acid (170 mg g, 0.378 mmol) is reduced with NaBH4 (29 mg, 0.756 mmol) analogous to Example 3 to give the title product (120 mg, 71%).
Sources & evidence
- ORD record
- ord-a4de3f0803c04642b5e1ba97b6b445a3
- Source dataset
- uspto-grants-2009_08
- Patent number
- US07579488B2
Reaction notes
Loading…